Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Emraclidine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bristol’ schizophrenia drug nears approval, AbbVie hope to provide competition
    Bristol’ schizophrenia drug nears approval, AbbVie hope to provide competition

    19 Aug 2024

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/bms-karxt-schizophrenia-approval-abbvie/724555/

    BIOPHARMADIVE
    19 Aug 2024
    Share Share
    AbbVie Completes Acquisition of Cerevel Therapeutics
    AbbVie Completes Acquisition of Cerevel Therapeutics

    01 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/abbvie-completes-acquisition-of-cerevel-therapeutics-302212336.html

    PR NEWSWIRE
    01 Aug 2024
    Share Share
    AbbVie to acquire Cerevel for $8.7 billion
    AbbVie to acquire Cerevel for $8.7 billion

    07 Dec 2023

    // Ananya M. Rajesh REUTERS

    https://www.reuters.com/markets/deals/abbvie-buy-drug-developer-cerevel-87-billion-2023-12-06/

    Ananya M. Rajesh REUTERS
    07 Dec 2023
    Share Share